1. Home
  2. HROW vs WLFC Comparison

HROW vs WLFC Comparison

Compare HROW & WLFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • WLFC
  • Stock Information
  • Founded
  • HROW 1998
  • WLFC 1985
  • Country
  • HROW United States
  • WLFC United States
  • Employees
  • HROW N/A
  • WLFC N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • WLFC Industrial Specialties
  • Sector
  • HROW Health Care
  • WLFC Consumer Discretionary
  • Exchange
  • HROW Nasdaq
  • WLFC Nasdaq
  • Market Cap
  • HROW 1.1B
  • WLFC 983.1M
  • IPO Year
  • HROW N/A
  • WLFC 1996
  • Fundamental
  • Price
  • HROW $33.02
  • WLFC $149.37
  • Analyst Decision
  • HROW Strong Buy
  • WLFC
  • Analyst Count
  • HROW 7
  • WLFC 0
  • Target Price
  • HROW $61.83
  • WLFC N/A
  • AVG Volume (30 Days)
  • HROW 453.8K
  • WLFC 99.5K
  • Earning Date
  • HROW 08-11-2025
  • WLFC 08-05-2025
  • Dividend Yield
  • HROW N/A
  • WLFC 0.67%
  • EPS Growth
  • HROW N/A
  • WLFC 30.03
  • EPS
  • HROW N/A
  • WLFC 16.84
  • Revenue
  • HROW $212,858,000.00
  • WLFC $637,163,000.00
  • Revenue This Year
  • HROW $46.17
  • WLFC $16.35
  • Revenue Next Year
  • HROW $39.97
  • WLFC $10.53
  • P/E Ratio
  • HROW N/A
  • WLFC $8.85
  • Revenue Growth
  • HROW 53.49
  • WLFC 32.40
  • 52 Week Low
  • HROW $20.85
  • WLFC $85.05
  • 52 Week High
  • HROW $59.23
  • WLFC $235.43
  • Technical
  • Relative Strength Index (RSI)
  • HROW 48.64
  • WLFC 59.26
  • Support Level
  • HROW $30.12
  • WLFC $132.50
  • Resistance Level
  • HROW $33.90
  • WLFC $145.00
  • Average True Range (ATR)
  • HROW 1.70
  • WLFC 4.65
  • MACD
  • HROW -0.50
  • WLFC 0.76
  • Stochastic Oscillator
  • HROW 36.39
  • WLFC 89.73

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About WLFC Willis Lease Finance Corporation

Willis Lease Finance Corp, with its subsidiaries, is a lessor and servicer of commercial aircraft and aircraft engines. The company has two reportable business segments, which include Leasing and Related Operations and Spare Parts Sales. A majority of its revenue is generated from the Leasing and Related Operations segment, which involves acquiring and leasing, under operating leases, commercial aircraft, aircraft engines, and other aircraft equipment and the selective purchase and resale of commercial aircraft engines, aircraft equipment, and other related businesses. Geographically, the company derives maximum revenue from the United States, followed by Europe, Asia-Pacific (excluding India), India, South America, Canada, Central America, and the Middle East.

Share on Social Networks: